Search

everythinglearnresearchcommunity

for

Search:↓

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Transplant patients often get skin problems, with treatments varying by condition.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Peanut allergies can be transferred through organ transplants.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The patient improved after antiviral treatment for a viral infection.

Polyunsaturated fatty acids, like arachidonic acid and eicosapentaenoic acid, can promote hair growth and may help treat hair loss.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.